chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: little bit of upper respiratory symptoms; feel like I've been hit by a truck; headache; sinus pressure; vomiting; fatigue; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history of patient's body attacking itself during immune responses.The patient's concomitant medications were not reported. On an unspecified date, the patient experienced a little bit of upper respiratory symptoms yesterday. She felt like she had been hit by a truck, had headache, sinus pressure, vomiting and fatigue. The outcome of the event was unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Arm was sore after receiving the vaccine; has been experiencing itchiness and redness at injection site; has been experiencing itchiness and redness at injection site; This is a spontaneous report from a Pfizer Sponsored Program, received from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration first dose on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm was sore after receiving the vaccine and has been experiencing itchiness and redness at injection site has been putting cream on it to try and subside the reaction wanted to know if these are normal reactions. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: to get a rash that weekend.; This is a spontaneous report from a Pfizer-sponsored program. A consumer (patient) reported for a male patient of an unspecified age received the first dose of bnt162b2 (BNT162B2, lot/batch number and expiry date were not reported), via an unspecified route of administration on 21Jan2021 at SINGLE DOSE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced a rash that weekend (Jan2021). The outcome of event was unknown.    Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Drug ineffective, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: got tested positive; got tested positive; This is a spontaneous report from a Pfizer Sponsored Program . A contactable consumer reported for himself that a male patient with unknown age received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration on an unknown date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. Patient received the first dose of the Pfizer shot and he got tested positive and had symptoms (but the caller did not provide the specific symptoms). He is scheduled to get the second dose on 16Feb2021. Patient wanted to know if he can take the second dose on the scheduled one or he should delay it. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Headache, Nausea, Pyrexia
Clinical narrative: Really bad headache; Fever; Nausea; Upset stomach; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect, received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on 25Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got her second dose of vaccine on 25Jan2021 and that night she experienced really bad headache, fever, nausea, and upset stomach on 25Jan2021. She was still having these symptoms and wanted to know if this was normal. Outcome of the events was not recovered.    Information about batch/lot number has been requested.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: 12Jan was the first dose of the covid vaccine, 18Jan she had a positive covid test; Congestion; Cough; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored program. A 64-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on her right arm, via an unspecified route of administration on 12Jan2021 08:00 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient started to feel symptoms on 16Jan2021 09:00, which is cough and congestion. On 18Jan2021, she tested positive for COVID. She is scheduled for getting her second dose on 09Feb2021. She is calling to question if she should get the second dose since she was diagnosed with COVID. The outcome of the events was unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Malaise, Nasal congestion, Nasopharyngitis
Clinical narrative: he has cold like symptoms; Stuffed up nose; doesn't feel really good; pain in the site area; slept a lot and was tired; slept a lot and was tired; his stomach is nauseous and queasy; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration in Jan2021 (also reported as "around 19Jan2021" or "19Jan2021 or 20Jan2021", pending clarification) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got his first COVID dose around 19Jan2021 (also reported as "19Jan2021 or 20Jan2021") and now he has cold like symptoms. Stuffed up nose, doesn't feel really good and wanted to know if this part of the COVID vaccine. On the first day, he had pain in the site area, slept a lot and was tired. It has been 10 days since the shot and he had symptoms of a cold and his stomach was nauseous and queasy (also reported as squeezy). The reporter wanted to know if this was a part of the side effects or does she need to call his primary care. She was told about symptoms to watch for within the first seven days and this was well beyond the seven days. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: he has cold like symptoms; Stuffed up nose; doesn't feel really good; pain in the site area; slept a lot and was tired; slept a lot and was tired; his stomach is nauseous and queasy; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration in Jan2021 (also reported as "around 19Jan2021" or "19Jan2021 or 20Jan2021", pending clarification) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got his first COVID dose around 19Jan2021 (also reported as "19Jan2021 or 20Jan2021") and now he has cold like symptoms. Stuffed up nose, doesn't feel really good and wanted to know if this part of the COVID vaccine. On the first day, he had pain in the site area, slept a lot and was tired. It has been 10 days since the shot and he had symptoms of a cold and his stomach was nauseous and queasy (also reported as squeezy). The reporter wanted to know if this was a part of the side effects or does she need to call his primary care. She was told about symptoms to watch for within the first seven days and this was well beyond the seven days. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Caller tested positive for covid-19; Caller tested positive for covid-19; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable consumer (patient) reported that female patient of an unspecified age received first dose of BNT162B2 (Lot number and expiry date not provided), via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  It was reported that the patient had first dose of the covid-19 vaccine on 17Dec2020 and she was tested positive for COVID-19 on 07Jan2021. She has not had her second dose, stated that MD said to wait 3 months because of antibodies, she would like information on what she should do. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 07Jan2021. The outcome of the events was unknown.    Information on the Lot/Batch Number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: Allergic reaction; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (patient) reported that a female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced an allergic reaction. On an unspecified date, the patient was hospitalized due to an unknown reason. The patient was inquiring if the company can help with hospital bills. Outcome of the event allergic reaction was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fall
Clinical narrative: He slipped and fell on the ice; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 27Jan2021 at a single for COVID-19 immunisation. Medical history and concomitant medications were not reported. Since receiving the vaccine, the patient slipped and fell on the ice on an unspecified date and was wondering if he can take Tylenol for the pain during the vaccination series. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Fall, Muscle disorder, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: He slipped and fell on the ice; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 27Jan2021 at a single for COVID-19 immunisation. Medical history and concomitant medications were not reported. Since receiving the vaccine, the patient slipped and fell on the ice on an unspecified date and was wondering if he can take Tylenol for the pain during the vaccination series. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: cold sore; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 31Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced cold sore on 01Feb2021. She was wondering if she is okay to use an anti-viral product. The outcome of the event was unknown.   Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Heart rate increased, Pruritus, Rash
Clinical narrative: Shortness of breath; Rapid heartbeat; Rash; Itching; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's husband) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot/batch number and expiry date unknown), via an unspecified route of administration on an unspecified date at single dose for an unspecified indication. The patient's medical history included she was allergic to silicone and sulfur. The patient's concomitant medications were not reported. The patient received the COVID vaccine on an unspecified date (reported as Friday) and two hours later, she experienced shortness of breath, rapid heartbeat, rash, and itching. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Covid vaccine 14 days ago and then contracted Covid/2 weeks afterward she became infected with covid; Covid vaccine 14 days ago and then contracted Covid/2 weeks afterward she became infected with covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program .  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated that she received the Covid vaccine 14 days before 01Feb2021 and then contracted Covid. She got the first dose of the covid vaccine on 23Dec2020, 2 weeks afterward (Jan2021) she became infected with covid. The outcome of events was unknown. Patient wanted to know when she can get the 2nd dose or how to proceed.  Information on Lot/Batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Body temperature, Body temperature increased, Eye pain
Clinical narrative: severe eye pain in right eye; couldn't see or read; big increase in blood pressure and temperature; big increase in blood pressure and temperature; This is a spontaneous report from a Pfizer-sponsored program.  A contactable consumer (patient himself) reported that a male patient of an unspecified age received the first (1st) dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he had reaction to vaccine and stated that on the day of the vaccine on an unspecified date in Jan2021, he had severe eye pain in right eye, went to bed that night, and woke up next morning, couldn't see or read even using his eye glasses. He went to a pharmacy and bought some cheap reading glasses, but it didn't help much. The last couple of days on an unspecified date in 2021, the patient had big increase in blood pressure and temperature, but it didn't feel bad. Therapeutic measures were taken as a result of the event "couldn't see or read." The patient was not recovered from the event "couldn't see or read," while the outcome of the events "severe eye pain in right eye and big increase in blood pressure and temperature" was unknown.  Information on the batch/lot number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: severe eye pain in right eye; couldn't see or read; big increase in blood pressure and temperature; big increase in blood pressure and temperature; This is a spontaneous report from a Pfizer-sponsored program.  A contactable consumer (patient himself) reported that a male patient of an unspecified age received the first (1st) dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he had reaction to vaccine and stated that on the day of the vaccine on an unspecified date in Jan2021, he had severe eye pain in right eye, went to bed that night, and woke up next morning, couldn't see or read even using his eye glasses. He went to a pharmacy and bought some cheap reading glasses, but it didn't help much. The last couple of days on an unspecified date in 2021, the patient had big increase in blood pressure and temperature, but it didn't feel bad. Therapeutic measures were taken as a result of the event "couldn't see or read." The patient was not recovered from the event "couldn't see or read," while the outcome of the events "severe eye pain in right eye and big increase in blood pressure and temperature" was unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, SARS-CoV-2 antibody test negative
Clinical narrative: last dose of Covid vaccine on 9Jan and then had an antibody test on the 27 and it came back negative; This is a spontaneous report from a contactable pharmacist (patient) via Pfizer-sponsored program. A female patient of an unspecified age received the second single dose of BNT162B2 (PFIZERBIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on 09Jan2021 for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took first single dose of BNT162B2 (Pfizer BioNTech) on an unspecified date for COVID-19 immunization. The patient received both doses of the Pfizer BioNTech COVID-19 vaccine. The patient's last dose of Covid vaccine was on 09Jan2021 and then had her blood tested on 27Jan2021. She wasn't sure about the type of test that she had but she had mentioned a "polypeptide nucleotide test" and said that she had the standard test for all blood centers. She further stated that her antibody test came back negative. She was wondering if the test should show that she has antibodies. She wanted to know if that was typical. The event was assessed as non-serious.  Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Got Covid after getting the 1st dose of the vaccine; Got Covid after getting the 1st dose of the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 12Jan2021 (reported as 20 days ago from the time of the report) at SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient was supposed to go in tomorrow (02Feb2021) and get her 2nd dose, but she got COVID after getting the 1st dose of the vaccine on an unspecified date. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Positive Rapid COVID-19 Test on the 29th; This is a spontaneous report from a Pfizer-sponsored program. A contactable other healthcare professional (HCP) reporting for herself reported that a 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 22Jan2021 at singe dose for covid-19 immunisation. Medical history reported as none. There were no concomitant medications. The patient experienced Positive Rapid COVID-19 Test on 29Jan2021, and she was due for her second COVID test on 17Feb2021, so she was calling to see if it was still okay for her to get her second dose of the vaccine as scheduled, since she has now had COVID. The patient stated that she did not think there was anything else relevant, other than the fact that she was in contact with people who were potentially COVID positive in the facility where she works. Patient stated that they perform COVID testing at her job, so she was around people who were suspected to have COVID. The outcome of the event was unknown.  Information about Batch/Lot number has been requested.; Sender's Comments: There is no reasonable possibility that the event "positive rapid COVID19 test" within 7 days from the administration of the first dose was related to BNT162b.  This is more likely associated with an earlier acquired infection during these pandemic times.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This is a spontaneous report from a contactable consumer (patient's husband) via a Pfizer-Sponsored Program. A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: UNKNOWN) via an unspecified route of administration on 21Jan2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date the patient experienced headache. The reporter and the patient both had their Pfizer COVID-19 vaccines on 21Jan2021, and the second dose would be given on 11Feb2021. The reporter stated that the patient had a very bad headache now and wanted to know if she could take Excedrin Migraine because this is what she had been using in the past when she had a headache. The clinical outcome of the event headache was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: covid positive; covid positive; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (wife) reported that a male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 23Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Caller calling on behalf of the husband who was in a long term care facility. He was given 1st dose on 23Jan2021, thereafter tested covid positive in 2021. He was scheduled to receive the 2nd dose on 23Feb2021. He was advised not to have it because he tested positive. Wife wanted to know if it's true. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: mild soreness on injected arm after the first dose; This is a spontaneous report from a contactable nurse (the patient) from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration in the arm on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if she could take painkillers before and after her second dose. She mentioned having mild soreness on injected arm after the first dose (unspecified date). The patient had one dose of the Pfizer-BioNTech COVID-19 Vaccine and didn't take any pain killers. She just had a slightly sore arm. She heard something about the second dose can give you a headache. She asked what was recommended on taking pain medication like acetaminophen, ibuprofen, or diphenhydramine hcl (BENADRYL) before and/or after vaccination? The clinical outcome of mild soreness on injected arm after the first dose was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021101338 Pfizer
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Inappropriate schedule of product administration
Clinical narrative: fever; chills; aches; headache; fatigue; loss of appetite; Dulled taste; patient received the first dose on 12Jan2021 and the second dose was on 29Jan2021; This is a spontaneous report from a contactable consumer (patient). A 29-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: El9362; expiration date: unknown) at vaccination age of 29-year-old via an unspecified route of administration in the left arm on 29Jan2021 16:45 at a single dose for covid-19 immunization. Medical history included hypothyroidism, PCOS (polycystic ovarian syndrome) and penicillin allergy. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included levothyroxine, metformin and vitamin nos (MULTIVITAMINS). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: Ek4176) at vaccination age of 29-year-old via an unspecified route of administration in the left arm on 12Jan2021 16:45 at a single dose for covid-19 immunization but had lump on neck, sore arm, diarrhea starting day 3 through today and sore rib. The patient received the most recent COVID-19 vaccine in a hospital. It was reported that the patient received the first dose on 12Jan2021 and the second dose was on 29Jan2021. On an unspecified date after the second dose, the patient had fever, chills, aches, headache, fatigue, loss of appetite and dulled taste. It was unknown if the patient received treatment for the adverse events and events were considered as non-serious. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Taste disorder
Clinical narrative: fever; chills; aches; headache; fatigue; loss of appetite; Dulled taste; patient received the first dose on 12Jan2021 and the second dose was on 29Jan2021; This is a spontaneous report from a contactable consumer (patient). A 29-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: El9362; expiration date: unknown) at vaccination age of 29-year-old via an unspecified route of administration in the left arm on 29Jan2021 16:45 at a single dose for covid-19 immunization. Medical history included hypothyroidism, PCOS (polycystic ovarian syndrome) and penicillin allergy. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included levothyroxine, metformin and vitamin nos (MULTIVITAMINS). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: Ek4176) at vaccination age of 29-year-old via an unspecified route of administration in the left arm on 12Jan2021 16:45 at a single dose for covid-19 immunization but had lump on neck, sore arm, diarrhea starting day 3 through today and sore rib. The patient received the most recent COVID-19 vaccine in a hospital. It was reported that the patient received the first dose on 12Jan2021 and the second dose was on 29Jan2021. On an unspecified date after the second dose, the patient had fever, chills, aches, headache, fatigue, loss of appetite and dulled taste. It was unknown if the patient received treatment for the adverse events and events were considered as non-serious. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headaches for a week; This is a spontaneous report from a contactable other healthcare professional (patient himself). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK5730), intramuscularly on the left arm, on 05Jan2021 14:00, at single dose, for covid-19 immunization. Medical history included chronic back pain, blood pressure, and pain. Unspecified concomitant medications were taken for blood pressure and pain. The patient did not have COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After the first injection, the patient had headaches for a week on Jan2021. No treatment was received for the headaches and the patient recovered from it on Jan2021. The patient has not been COVID-tested post-vaccination.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Hangover, Headache, Lethargy
Clinical narrative: Body aches; Puttered around the house, then lost energy around noon; headache upon waking; felt like I had a hangover; Lethargic all day; Fever 99.5-100.2; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received second dose of BNT162B2 (lot number: El9265), via an unspecified route of administration on 29Jan2021 13:00 at single dose in the left arm for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included levothyroxine sodium (UNITHROID). The patient previously took first dose of BNT162B2 (lot number: El324) at the age of 62 year-old on 08Jan2021 13:00 in the left arm and experienced minor injection site soreness. On 30Jan2021 07:00, the patient experienced headache upon waking Saturday morning and felt like she had a hangover. She felt lethargic all day. She had fever 99.5-100.2 from 7pm- 9pm on Saturday night. She experienced body aches on Sunday morning, 31Jan2021. Puttered around the house, then lost energy around noon. She felt ok but not back to normal energy level yet. Stated she is going to work tomorrow. The patient was not pregnant at the time of vaccination. The patient did not receive any treatment for the events. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included body temperature: 99.5-100.2 on 30Jan2021. The outcome of the events was recovered in Jan2021.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body aches; Puttered around the house, then lost energy around noon; headache upon waking; felt like I had a hangover; Lethargic all day; Fever 99.5-100.2; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received second dose of BNT162B2 (lot number: El9265), via an unspecified route of administration on 29Jan2021 13:00 at single dose in the left arm for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included levothyroxine sodium (UNITHROID). The patient previously took first dose of BNT162B2 (lot number: El324) at the age of 62 year-old on 08Jan2021 13:00 in the left arm and experienced minor injection site soreness. On 30Jan2021 07:00, the patient experienced headache upon waking Saturday morning and felt like she had a hangover. She felt lethargic all day. She had fever 99.5-100.2 from 7pm- 9pm on Saturday night. She experienced body aches on Sunday morning, 31Jan2021. Puttered around the house, then lost energy around noon. She felt ok but not back to normal energy level yet. Stated she is going to work tomorrow. The patient was not pregnant at the time of vaccination. The patient did not receive any treatment for the events. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included body temperature: 99.5-100.2 on 30Jan2021. The outcome of the events was recovered in Jan2021.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Vaccination site pain
Clinical narrative: injection site soreness; severe back pain; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL8982), via an unspecified route of administration into the left arm on 29Jan2021 10:15 AM at a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date prior to vaccination. The patient's concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via an unspecified route of administration into the left arm on 09Jan2021 08:30 AM at a single dose for COVID-19 immunization and experienced injection site soreness. On 30Jan2021, patient experienced injection site soreness and severe back pain. The events were reported as non-serious and the patient was treated with diclofenac 100mg. Outcome of events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness
Clinical narrative: flu-like symptoms; headache; fatigue; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. Medical history included seizure disorder, depression, anxiety, mild hyperthyroidism and allergies to penicillin. Concomitant medication included carbamazepine, citalopram, buspirone hydrochloride (BUSPAR) and omeprazole. The patient previously received the first dose of BNT162B2 on 17Dec2020 (Age at vaccination: 41 years) for COVID-19 immunisation and experienced flu-like symptoms, headache, aches, chills, night sweats and more fatigue than normal. The patient experienced flu-like symptoms on an unspecified date. It was reported that with the second shot, the patient took ibuprofen shortly after receiving it and mainly had a headache and fatigue. Just for 24 hours after the shot did the patient have symptoms. The outcome of the events was recovered on an unspecified date.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache after the second shot; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable healthcare professional (HCP) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot unknown, second dose) solution for injection intramuscular on an unknown date (at an unknown age) at single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (first dose) for COVID-19 vaccination on an unknown date with no adverse effect reported. The patient completed the vaccination series, and she took some pain reliever for her headache after the second shot. The outcome of the event headache was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Rash
Clinical narrative: She has started developing rash all over her neck and now coming on to arm, it's a very bad rash; Right now it is getting kind of worse; She is feeling very bad after the vaccine; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient started to receive bnt162b2 (BNT162B2 also reported as Pfizer Covid vaccine, lot ENS318), via an unspecified route of administration from 30Jan2021 to 30Jan2021 at SINGLE DOSE for an unspecified indication. The patient's medical history was not reported. Concomitant medications included diclofenac, gabapentin, losartan, levothyroxine sodium (SYNTHROID), vitamin C (ASCORBIC ACID) and ergocalciferol (VITAMIN D). On 31Jan2021, she was feeling very bad after the vaccine administration and started developing rash all over her neck and now coming on to arm. Reported that it's a very bad rash and right now it was getting kind of worse (no treatment). The outcome of rash aggravated was not recovered; for other event was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Flushing, Ocular hyperaemia
Clinical narrative: Irritation and redness in both eyes; Flushing of the face; Irritation and redness in both eyes; This is a spontaneous report received from a non-contactable consumer (patient herself). An elderly female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Lot number: EL9264), via an unspecified route of administration on arm left on 05Feb2021 16:15 at single dose for COVID-19 immunisation at hospital. Medical history included occasional rosacea with stress or excitement. Concomitant medication included metformin and zinc, which are received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took tetracycline and experienced allergy. On 05Feb2021 16:30, the patient experienced irritation and redness in both eyes and flushing of the face. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was not received any treatment for the events. The events were assessed as non-serious by the reporter. Outcome of the events was recovered on unspecified date in 2021.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: exhausted; body aches; headache; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient (non-pregnant) received second dose of (BNT162B2, Solution for injection, Batch/lot: EL3248), via an unspecified route of administration on 03Feb2021 14:30 at single dose in left arm for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Historical vaccine of BNT162B2 for covid-19 immunisation, (administration date: 15Jan2021, time=02:30 PM, vaccine location: Left arm, dose number: 1, lot number: EL3248). Concomitant medication included desvenlafaxine succinate (PRISTIQ), levofloxacin (LEVOXAL), ergocalciferol (VIT D), ascorbic acid (VIT C), zinc, calcium. The patient was exhausted, body aches and had headache on 04Feb2021 and it started 04:30 AM. The treatment was not received for the adverse events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies. The outcome of the events was recovered on an unspecified date of Feb2021.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Muscle spasms, Pain
Clinical narrative: I slept all day; I could not eat; I could not get out of bed, I hurt so bad/Body aches; Muscle spasms; Headache; Tired; I had a 100.4 temperature for 2 days; This is a spontaneous report from a contactable consumer (reporting for herself). A 52-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 29Jan2021 to 29Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) for unspecified indication. On 30Jan2021, the patient stated that "I slept all day, I could not eat, I could not get out of bed, I hurt so bad and has body aches, muscle spasms, headache, tired and I had a 100.4 temperature for 2 days." The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 26Nov2020. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence
Clinical narrative: I slept all day; I could not eat; I could not get out of bed, I hurt so bad/Body aches; Muscle spasms; Headache; Tired; I had a 100.4 temperature for 2 days; This is a spontaneous report from a contactable consumer (reporting for herself). A 52-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 29Jan2021 to 29Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) for unspecified indication. On 30Jan2021, the patient stated that "I slept all day, I could not eat, I could not get out of bed, I hurt so bad and has body aches, muscle spasms, headache, tired and I had a 100.4 temperature for 2 days." The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 26Nov2020. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild soreness at the injection site; This is a spontaneous report from a non-contactable consumer (patient). A 78-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EM9809), via an unspecified route of administration on left arm on 08Feb2021 at the age of 78 years old at a single dose for COVID-19 immunisation at Doctor's office/urgent care. Medical history included high cholesterol. Allergies to medications, food, or other products was none. Concomitant medications included unspecified medications. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. Historical vaccination included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) received at the age of 78 years old on an unknown date for COVID-19 immunization. On 08Feb2021, the patient experienced mild soreness at the injection site. The patient assessed the event as non-serious. It was unknown if the treatment was received in response to the adverse event. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient was recovering from the event.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Very mild soreness at the injection site; Very Mild fatigue; This is a spontaneous report from a non-contactable consumer (female patient). A 78-year-old female non pregnant patient received second dose of bnt162b2 (Formulation: Solution for injection, Lot number: em9809) via unspecified route of administration on left arm, on an unknown date at single dose for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously took historical vaccine, first dose of bnt162b2 for COVID-19 immunization. It was reported that the patient experienced very mild soreness at the injection site and very mild fatigue on 08Feb2021. The patient administered most recent COVID-19 vaccine at doctor's office/urgent care, had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received medication (unspecified) within 2 weeks of vaccination (as reported). The patient didn't receive treatment for the adverse events. The patient had not diagnosed with COVID-19 prior to vaccination and since the vaccination. It was reported that patient had no allergies to medications, food, or other products. The seriousness of the events was reported as non-serious by the reporter. The outcome of the events was reported as recovered on an unknown date in Feb2021.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Back pain, Burning sensation, Dry skin, Malaise, Myalgia
Clinical narrative: Muscles were aching on the opposite shoulder/Neck and back and shoulders, arms; I do get achy muscles; Rash like dry skin on cheeks and like nose; it's red, kind of burns but it's not hot; Rash like dry skin on cheeks and like nose; it's red, kind of burns but it's not hot; Not feeling well/not feeling really good; Rash like dry skin on cheeks and like nose; it's red, kind of burns but it's not hot; Muscles were aching on the opposite shoulder/Neck and back and shoulders, arms; I do get achy muscles; Muscles were aching on the opposite shoulder/Neck and back and shoulders, arms; I do get achy muscles; Muscles were aching on the opposite shoulder/Neck and back and shoulders, arms; I do get achy muscles; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration (right arm) on Jan2021, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had the shot on Friday and patient believes patient is having reactions to this, patient is not sure because it was not really listed. First of all, they mentioned like muscle aches on where you got the shot but patient's muscles were aching on the opposite shoulder. Patient got the shot in the right arm and patient's muscles were aching on the other side. That's one minor thing because it's like in patient's neck and back and patient's shoulders, like patient's arms. Patient do get achy muscles now and then. Paitent noticed that, the first thing, patient doesn't know if it's possible that it could be on the other of the side of that. It could be one of them but that's not what is really concerning patient. Actually, the one thing it said on the thing that it's a possibility you might get a puffy face. Patient has a rash, like dry, dry skin on patient's cheeks and like patient's nose and it's red that's one thing. Patient was sure that's from the shot. But patient's real concern, patient's main concern is, patient was in home service. Patient helps out people that are either handicapped or whatever and patient want to get this done. Does this mean patient should not have the second shot because patient was having like the red face, it kind of burns but it's not hot.Patient was not feeling really good because of the shot. This was the only number that patient was given when patient got the shot and patient would like to know what your purpose is. Patient was so angry for this (call issue). The outcome of the events was unknown.  Information on the Lot/Batch has been requested.